Risk Factors for Pancreatic Neuroendocrine Tumors: A Clinic-Based Case-Control Study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pancreas

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPA.0000000000000234PMID 25291526PMCID PMC4267883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zollinger-Ellison syndrome associated with a history of alcohol abuse: coincidence or consequence?

  2011cited by this paper
• Survival analyses of pancreatic neuroendocrine tumors: Contrasting institutional databases with population-based studies.

  2011cited by this paper
• Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.

  2011cited by this paper
• Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L

  2009cited by this paper
• New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

  2009cited by this paper
• Familial gastrointestinal carcinoid tumours and associated cancers.

  2009cited by this paper
• Mitochondrial Genetic Polymorphisms Do Not Predict Survival in Patients with Pancreatic Cancer

  2008cited by this paper
• Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

  2008influential reference
• Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study

  2008cited by this paper
• Risk factors associated with neuroendocrine tumors: A U.S.‐based case–control study

  2008influential reference
• Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

  2008cited by this paper
• Multiple endocrine neoplasia syndromes.

  2008cited by this paper
• Insulinoma.

  2008cited by this paper
• Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

  2007cited by this paper
• The multiple endocrine neoplasia syndromes.

  2007cited by this paper
• Insulinoma.

  2005cited by this paper
• von Hippel-Lindau disease.

  2003cited by this paper
• Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study

  2003cited by this paper
• The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case–control study

  2002cited by this paper
• Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings.

  1994cited by this paper
• Glucose Intolerance in the Carcinoid Syndrome

  1975cited by this paper

• Incidence and risk factors for insulinoma diagnosed in dogs under primary veterinary care in the UK

  2025cites this paper
• Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms

  2025cites this paper
• Epidemiology of Neuroendocrine Neoplasia Worldwide: A Review of the Literature (2012–2022)

  2025cites this paper
• The geographical distribution of neuroendocrine neoplasms in England (2012–2018)

  2025cites this paper
• Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the All of Us Research Program

  2025influential citation
• Association of modifiable risk factors and telomere length with five neuroendocrine neoplasms: a bidirectional Mendelian randomization study

  2025cites this paper
• The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images

  2025cites this paper
• Pancreatic Neuroendocrine Tumors—A Descriptive Study of the Presenting Features in a 20-Year Surgical Resection Cohort at a Tertiary Institution

  2025cites this paper
• Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions

  2025cites this paper
• PANCREATIC NEUROENDOCRINE NEOPLASMS (pNENs): GENETIC AND ENVIRONMENTAL BIOMARKERS FOR RISK OF OCCURRENCE AND PROGNOSIS.

  2025cites this paper
• Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma

  2025cites this paper
• Pancreatic Neuroendocrine Tumors—Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report

  2025cites this paper
• Pancreatic neuroendocrine tumor with solitary splenic metastasis and synchronous renal cell carcinoma: A rare case report

  2024cites this paper
• Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group

  2024influential citation
• The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001–2018 United States Cancer Statistics Databases

  2024cites this paper
• Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract—Comparison of the Risk Factors and Non-Surgical Treatment Efficacy

  2023cites this paper
• Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England

  2023cites this paper
• Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?

  2023cites this paper
• Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity

  2023cites this paper
• Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms

  2023cites this paper
• Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome

  2023cites this paper
• Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe

  2023cites this paper
• Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms

  2022cites this paper
• Diagnostic Value of Endoscopic Ultrasound for Detecting Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms

  2022cites this paper
• Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives

  2022cites this paper
• Bone Loss in Patients with Pancreatic Neuroendocrine Tumors

  2022cites this paper
• Lifestyle Factors and Development and Natural Course of Gastroenteropancreatic Neuroendocrine Tumors: A Review of the Literature

  2022cites this paper
• Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study

  2022cites this paper
• A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

  2021cites this paper
• Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors

  2021cites this paper
• An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan

  2021cites this paper
• Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case–control study

  2021cites this paper
• Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) mul

  2021cites this paper
• Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms

  2020cites this paper
• Germline genetic variability in pancreatic cancer risk and prognosis.

  2020cites this paper
• Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

  2020cites this paper
• Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective

  2020cites this paper
• Microbiota Alterations in Gastrointestinal Cancers

  2020cites this paper
• The epidemiologic trends of neuroendocrine tumors in Taiwan: an updated analysis of a nation-wide population-based study

  2020cites this paper
• Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study

  2020cites this paper
• High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour

  2020cites this paper
• Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary Cancer: A US Population-Based Study

  2019cites this paper
• Gastroenterology

  2019cites this paper
• Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome

  2019cites this paper
• The role of the antidiabetic drug metformin in the treatment of endocrine tumors.

  2019cites this paper
• The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors

  2019cites this paper
• Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors

  2018cites this paper
• Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.

  2018cites this paper
• Neuroendocrine Tumors: a Nosologic Framework

  2018cites this paper
• Pancreatic carcinoma underlying a complex presentation in late pregnancy: a case report

  2018cites this paper
• Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?

  2018cites this paper
• The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation‐wide cancer registry‐based study from Taiwan

  2018cites this paper
• The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study

  2018cites this paper
• Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

  2018cites this paper
• A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component

  2017influential citation
• Hereditary pancreatic cancer: related syndromes and clinical perspective

  2017cites this paper
• Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.

  2017cites this paper
• Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?

  2016cites this paper
• Neuroendocrine tumors and smoking

  2016cites this paper
• Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study

  2016cites this paper
• Using Electronic Health Records for Population Health Research: A Review of Methods and Applications.

  2016cites this paper
• Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center

  2016cites this paper
• Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors

  2016cites this paper
• Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study

  2016influential citation
• Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.

  2016cites this paper
• Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.

  2016influential citation
• Disseminated Well-Di ff erentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome

  year unknowncites this paper
• World Journal of Gastroenterology

  year unknowncites this paper